Do you want to read an article? Please log in or register.
The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation
Heart FailureTherapy and Intervention
Related content
Heart, Artery and Coronary DiseasesTherapy and Intervention
Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The CAMRA CardioLink-2 Study
Circulation
Chan V, Mazer CD, Ali FM, Quan A, Ruel M, de Varennes BE, Gregory AJ, Bouchard D, Whitlock RP, Chu MWA, Dokollari A, Mesana T, Bhatt DL, Latter DA, Zuo F, Tsang W, Teoh H, Jüni P, Leong-Poi H, Verma S
doi: 10.1161/CIRCULATIONAHA.120.046853
Heart, Artery and Coronary DiseasesTherapy and Intervention
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
Am Heart J.
Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Therkelsen CJ, Tilsted HH, Jensen LO, Nepper-Christensen L, Sadjadieh G, Engstrøm T
doi: 10.1016/j.ahj.2018.05.018.
Heart Failure
Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial
JAMA Cardiol
Lindenfeld J, Abraham WT, Grayburn PA, Kar S, Asch FM, Lim DS, Nie H, Singhal P, Sundareswaran KS, Weissman NJ, Mack MJ, Stone GW, Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) Investigators.
doi: 10.1001/jamacardio.2020.7200
Heart, Artery and Coronary Diseases
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 years
Eur J Heart Fail.
Iung B, Armoiry X, Vahanian A, Boutitie F, Mewton N, Trochu JN, Lefèvre T, Messika-Zeitoun D, Guerin P, Cormier B, Brochet E, Thibault H, Himbert D, Thivolet S, Leurent G, Bonnet G, Donal E, Piriou N, Piot C, Habib G, Rouleau F, Carrié D, Nejjari M, Ohlmann P, Etienne CS, Leroux L, Gilard M, Samson G, Rioufol G, Maucort-Boulch D, Obadia JF, MITRA-FR Investigators.
doi: 10.1002/ejhf.1616.
Heart, Artery and Coronary Diseases
New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation
JAMA Cardiol.
Packer M, Grayburn PA
doi: 10.1001/jamacardio.2019.5971.
Heart, Artery and Coronary DiseasesHeart Failure
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
N Engl J Med.
Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefèvre T, Piot C, Rouleau F, Carrié D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N, MITRA-FR Investigators
doi: 10.1056/NEJMoa1805374.
Heart, Artery and Coronary DiseasesHeart FailureTherapy and Intervention
Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial
J Am Coll Cardiol.
Asch FM, Grayburn PA, Siegel RJ, Kar S, Lim DS, Zaroff JG, Mishell JM, Whisenant B, Mack MJ, Lindenfeld J, Abraham WT, Stone GW, Weissman NJ, COAPT Investigators.
doi: 10.1016/j.jacc.2019.09.017.
COMMENTED
Heart Failure
Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials
★ 3
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
ESC Heart Fail
Spannella F, Giulietti F, Filipponi A, Sarzani R
doi: 10.1002/ehf2.13002
Heart, Artery and Coronary Diseases
An Appraisal of the Association of Clinical Outcomes With the Severity of Regurgitant Volume Relative to End-Diastolic Volume in Patients With Secondary Mitral Regurgitation
JAMA Cardiol.
Gaasch WH, Aurigemma GP, Meyer TE
doi: 10.1001/jamacardio.2019.5980.